Aspiring giants: How small pharmas can drive to $1 billion - and beyond

Only a few small companies have managed to catapult their revenue over the $1 billion mark over the past two decades in the global pharmaceutical industry. Whether they chose to expand their therapeutic area focus and product portfolios, enter new geographies, or grow their core business, these aspiring giants pursued three distinct strategies to jump-start growth:

• Leveraged core product and technology capabilities to launch differentiated products
• Used mergers and acquisitions to gain new products and/or expand geographic presence
• Built a strong, stable leadership team armed with a compelling vision and relentless drive

This report from PwC studies 30 companies that catapulted themselves beyond the $1 billion revenue mark and identifies what smaller, ambitious pharmaceutical companies should do to earn their first $1 billion in annual revenues.